Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Prochlorperazine, formerly sold under the brand name Compazine among others, is a medication used to treat nausea, migraines, schizophrenia, psychosis and anxiety. It is a less preferred medication for anxiety. It may be taken by mouth, rectally, injection into a vein, or injection into a muscle.
Community, Culture & Applications
Explore the main themes, entities and connections around Prochlorperazine. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
effects medication may include side united antipsychotic used use states name injection migraine nausea symptoms action available commonly anxiety drug
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Prochlorperazine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Prochlorperazine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Prochlorperazine | ATC code | N05AB04 (WHO) | 1.00 | infobox |
| Prochlorperazine | Bioavailability | Unknown, but presumed substantial | 1.00 | infobox |
| Prochlorperazine | CAS Number | 58-38-8 Y | 1.00 | infobox |
| Prochlorperazine | ChEBI | CHEBI:8435 Y | 1.00 | infobox |
| Prochlorperazine | ChEMBL | ChEMBL728 Y | 1.00 | infobox |
| Prochlorperazine | ChemSpider | 4748 Y | 1.00 | infobox |
| Prochlorperazine | CompTox Dashboard (EPA) | DTXSID7023514 | 1.00 | infobox |
| Prochlorperazine | Drug class | Typical antipsychotic | 1.00 | infobox |
| Prochlorperazine | DrugBank | DB00433 Y | 1.00 | infobox |
| Prochlorperazine | ECHA InfoCard | 100.000.345 | 1.00 | infobox |
| Prochlorperazine | Elimination half-life | 4–8 hours, differs with the method of administration; 24 hours accounting for enterohepatic recirculation | 1.00 | infobox |
| Prochlorperazine | Excretion | Bile duct, (colored) inactive metabolites in urine | 1.00 | infobox |
| Prochlorperazine | Formula | C20H24ClN3S | 1.00 | infobox |
| Prochlorperazine | IUPHAR/BPS | 7279 | 1.00 | infobox |
| Prochlorperazine | KEGG | D00493 Y | 1.00 | infobox |
| Prochlorperazine | Legal status | AU: S4 (Prescription only) / S3 | 1.00 | infobox |
| Prochlorperazine | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Prochlorperazine | Legal status | UK: POM (Prescription only) / P | 1.00 | infobox |
| Prochlorperazine | Legal status | US: ℞-only | 1.00 | infobox |
| Prochlorperazine | License data | US DailyMed: Prochlorperazine | 1.00 | infobox |
| Prochlorperazine | MedlinePlus | a682116 | 1.00 | infobox |
| Prochlorperazine | Metabolism | Mainly Liver (CYP2D6 and/or CYP3A4) | 1.00 | infobox |
| Prochlorperazine | Molar mass | 373.94 g·mol−1 | 1.00 | infobox |
| Prochlorperazine | Pregnancy category | AU: C | 1.00 | infobox |
| Prochlorperazine | Protein binding | 91–99% | 1.00 | infobox |
| Prochlorperazine | PubChem CID | 4917 | 1.00 | infobox |
| Prochlorperazine | Routes of administration | Oral administration, rectal administration, intramuscular injection, intravenous injection (IV) | 1.00 | infobox |
| Prochlorperazine | Trade names | Compazine, Stemetil, others | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.